Patents-Review.com
ClassID:

21264 ⎘

A61K47/16 - CPC Classification

Classification description:

Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient; Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates

Sub-classes:
Recent Application in this class:
#1
20260108624
2026-04-23

METHODS AND COMPOSITIONS FOR TRANSPORT, STORAGE, AND DELIVERY OF NUCLEIC ACIDS AND OTHER MOLECULES

 #2
20250288597
2025-09-18

TREPROSTINIL SOFT MIST INHALANT

 #3
20250255965
2025-08-14

METHOD FOR SELECTING ADDITIVE FOR SUPPRESSING NITROSATION REACTION, AND FORMULATION FOR SUPPRESSING GENERATION OF NITROSO COMPOUNDS

 #4
20250250226
2025-08-07

IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF

 #5
20250241924
2025-07-31

TREATMENT OF ERECTILE DYSFUNCTION AND OTHER INDICATIONS

 #6
20250234860
2025-07-24

Preservatives for Cosmetic, Toiletry and Pharmaceutical Compositions

 #7
20250221912
2025-07-10

SKIN TREATMENT METHODS AND COMPOSITIONS WITH RETINOID AND DELIVERY SYSTEMS THEREOF

 #8
20250213520
2025-07-03

METHOD AND COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS

 #9
20250114458
2025-04-10

NIR BIOSAFE QR CODES WITH BIOINKJET PRINTING AND TAGGING

 #10
20250009886
2025-01-09

COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS

 #11
20240350636
2024-10-24

HYPERTONIC ANTIMICROBIAL THERAPEUTIC COMPOSITIONS

 #12
20240350635
2024-10-24

HYPERTONIC ANTIMICROBIAL THERAPEUTIC COMPOSITIONS

 #13
20240226277
2024-07-11

INFLUENZA-CORONAVIRUS COMBINATION VACCINES

 #14
20240180954
2024-06-06

CATIONIC LIPID

 #15
20240100011
2024-03-28

PEDIATRIC FORMULATIONS OF FERRIC CITRATE

 #16
20240066019
2024-02-29

Composition for enhancing mitochondrial function

 #17
20230372351
2023-11-23

Treatment of erectile dysfunction and other indications

 #18
20230320981
2023-10-12

SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ISOXAZOLINE COMPOUNDS

 #19
20230241214
2023-08-03

LIGHT-CONTROLLABLE SELF-ASSEMBLED COMPLEX AND NANOSYSTEM INCLUDING THE SAME

 #20
20230201131
2023-06-29

PERCUTANEOUS ABSORPTION PREPARATION COMPRISING DONEPEZIL WITH IMPROVED STABILITY

 #21
20230181557
2023-06-15

COMPOSITIONS FOR SYNERGISTICALLY ENHANCING MITOCHONDRIAL FUNCTION

 #22
20230119152
2023-04-20

POLYMER LINKERS AND THEIR USES

 #23
20230087789
2023-03-23

Composition for enhancing mitochondrial function

 #24
20230082788
2023-03-16

XANTHINE OXIDASE INHIBITOR FORMULATIONS

 #25
20220273774
2022-09-01

PROPHYLACTIC PROTECTION AGAINST VIRAL INFECTIONS

 #26
20220272973
2022-09-01

Preservatives for Cosmetic, Toiletry and Pharmaceutical Compositions

 #27
20220242820
2022-08-04

Ionizable compounds and compositions and uses thereof

 #28
20220183951
2022-06-16

Skin treatment methods and compositions with retinoid and delivery systems thereof

 #29
20220143189
2022-05-12

Carbohydrate conjugates as delivery agents for oligonucleotides

 #30
20220142984
2022-05-12

Soft Chewable Pharmaceutical Products

 #31
20220133783
2022-05-05

ANTIVIRAL COMPOSITION AND USE OF THE SAME

 #32
20220096493
2022-03-31

Precipitation resistant small molecule drug formulations

 #33
20220071997
2022-03-10

PREVENTION OF HIV-INFECTION

 #34
20220031727
2022-02-03

Formulation comprising a gemcitabine-prodrug

 #35
20220023207
2022-01-27

DRUG DELIVERY SYSTEM USING SOLUTION

 #36
20220016246
2022-01-20

Hypertonic antimicrobial therapeutic compositions

 #37
20220008541
2022-01-13

Carbohydrate conjugates as delivery agents for oligonucleotides

 #38
20210386867
2021-12-16

Filterable duocarmycin-containing antibody-drug conjugate compositions and related methods

 #39
20210346318
2021-11-11

EPINEPHRINE-BASED OPHTHALMIC COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHODS FOR FABRICATING THEREOF

 #40
20210315807
2021-10-14

HYDROGEL COMPOSITION AND HYDROGEL LENS

 #41
20210299262
2021-09-30

Composition and method for dual targeting in treatment of neuroendocrine tumors

 #42
20210299088
2021-09-30

Method and composition for preventing and treating viral infections

 #43
20210275471
2021-09-09

EPINEPHRINE-BASED OPHTHALMIC COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHODS FOR FABRICATING THEREOF

 #44
20210177749
2021-06-17

Solid oral pharmaceutical compositions for isoxazoline compounds

 #45
20210145758
2021-05-20

Encapsulated antimicrobials and related methods of treatment

 #46
20210128610
2021-05-06

Encapsulated antimicrobials and related methods of treatment

 #47
20210101875
2021-04-08

Aminoalcohol lipidoids and uses thereof

 #48
20210100807
2021-04-08

Treatment of erectile dysfunction and other indications

 #49
20200397810
2020-12-24

Formulation comprising a gemcitabine-prodrug

 #50
20200397783
2020-12-24

PREVENTION OF HIV-INFECTION

 #51
20200385369
2020-12-10

NEW BENZIMIDAZOLES DERIVATIVES AS TEC KINASES FAMILY INHIBITORS

 #52
20200329704
2020-10-22

Preservatives for cosmetic, toiletry and pharmaceutical compositions

 #53
20200297853
2020-09-24

Carbohydrate conjugates as delivery agents for oligonucleotides

 #54
20200268889
2020-08-27

(R)-12-HYDROXYSTEARIC ACID HYDRAZIDES AS GELATORS AND SELF-STANDING GELS THEREOF

 #55
20200237769
2020-07-30

Treatment of erectile dysfunction and other indications

 #56
20200179493
2020-06-11

Prophylactic protection against viral infections

 #57
20200171019
2020-06-04

Composition for enhancing mitochondrial function

 #58
20200170248
2020-06-04

Preservatives for cosmetic, toiletry and pharmaceutical compositions

 #59
20200155693
2020-05-21

Polymer linkers and their uses

 #60
20200140843
2020-05-07

METHOD FOR MONOMERIZING MATRIX METALLOPROTEINASE 7 (MMP-7) AGGREGATE

 #61
20200069580
2020-03-05

Ice pop medicament delivery system and method

 #62
20200038362
2020-02-06

Docetaxel albumin nanoparticle pharmaceutical composition, preparation method therefor and use thereof

 #63
20200009095
2020-01-09

Ibuprofen for Topical Administration

 #64
20200000718
2020-01-02

Solid Oral Pharmaceutical Compositions for Isoxazoline Compounds

 #65
20190365721
2019-12-05

Amine prodrugs of pharmaceutical compounds

 #66
20190365703
2019-12-05

Method and composition for preventing and treating viral infections

 #67
20190350970
2019-11-21

Topical antimicrobial formulations containing monovalent copper ions and systems for generating monovalent copper ions

 #68
20190314314
2019-10-17

Composition and method for dual targeting in treatment of neuroendocrine tumors

 #69
20190275170
2019-09-12

Polynucleotides encoding JAGGED1 for the treatment of Alagille syndrome

 #70
20190241530
2019-08-08

Crystalline forms, preparation methods and pharmaceutical compositions of ozanimod

 #71
20190224322
2019-07-25

COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS

 #72
20190201332
2019-07-04

Soft chewable pharmaceutical products

 #73
20190184018
2019-06-20

Carbohydrate conjugates as delivery agents for oligonucleotides

 #74
20190177289
2019-06-13

Aminoalcohol lipidoids and uses thereof

 #75
20190160006
2019-05-30

10-hydroxystearic acid compositions

 #76
20190127318
2019-05-02

Ionizable compounds and compositions and uses thereof

 #77
20190117565
2019-04-25

Soft Chewable Pharmaceutical Product

 #78
20190117564
2019-04-25

Soft Chewable Pharmaceutical Products

 #79
20190099493
2019-04-04

Targeting Lipids

 #80
20190083634
2019-03-21

Polymer linkers and their uses

 #81
20190083502
2019-03-21

Treatment of erectile dysfunction and other indications

 #82
20190076507
2019-03-14

Artificial Red Blood Cell Having Ability to Inhibit Conversion of Hemoglobin into Methemoglobin

 #83
20190022118
2019-01-24

Formulation comprising a gemcitabine-prodrug

 #84
20180369255
2018-12-27

Precipitation resistant small molecule drug formulations

 #85
20180362454
2018-12-20

Oil gelator

 #86
20180346909
2018-12-06

System and method for reversible photo-controlled gene silencing

 #87
20180333495
2018-11-22

Drug delivery device

 #88
20180326070
2018-11-15

CARBOHYDRATE CONJUGATES AS DELIVERY AGENTS FOR OLIGONUCLEOTIDES

 #89
20180319781
2018-11-08

Benzimidazoles derivatives as Tec kinases family inhibitors

 #90
20180318268
2018-11-08

AMINE PRODRUGS OF PHARMACEUTICAL COMPOUNDS

 #91
20180292387
2018-10-11

Antibiotic-based conjugates and methods of use thereof

 #92
20180289726
2018-10-11

Antibacterial agent against multidrug-resistant gram-positive bacteria and external agent

 #93
20180280517
2018-10-04

Nanocomposite, a Preparation Method Thereof and Method for Treating Cancer Using the Same

 #94
20180243196
2018-08-30

Skin treatment methods and compositions with retinoid and delivery systems thereof

 #95
20180154004
2018-06-07

Non-gelatin vaccine protectant composition and live attenuated influenza vaccine

 #96
20180036244
2018-02-08

Suspension containing nano-cocrystal and manufacturing method

 #97
20180028486
2018-02-01

Docetaxel albumin nanoparticle pharmaceutical composition, preparation method therefor and use thereof

 #98
20180028466
2018-02-01

Memantine transdermal delivery systems

 #99
20180008612
2018-01-11

TRANSDERMAL DELIVERY SYSTEM CONTAINING GALANTAMINE OR SALTS THEREOF

 #100
20170360035
2017-12-21

Preservatives for Cosmetic, Toiletry and Pharmaceutical Compositions

 #101
20170312288
2017-11-02

Treatment of erectile dysfunction and other indications

 #102
20170296576
2017-10-19

Method for treating cervical intraepithelial neoplasia using poly-gamma- glutamic acid

 #103
20170290766
2017-10-12

Soft chewable pharmaceutical products

 #104
20170266165
2017-09-21

Soft Chewable Pharmaceutical Products

 #105
20170258861
2017-09-14

Treatment of Herpes, Pseudomonas, Staph, and Hepatitis

 #106
20170216448
2017-08-03

Inhibitors of fusion between viral and cell membranes as well as compositions and methods of using them

 #107
20170204075
2017-07-20

Aminoalcohol lipidoids and uses thereof

 #108
20170143622
2017-05-25

STABLE LIQUID READY-TO-USE INJECTABLE FORMULATION OF BORTEZOMIB

 #109
20170112764
2017-04-27

Nanoemulsions having reversible continuous and dispersed phases

 #110
20170095498
2017-04-06

Formulation comprising a gemcitabine-prodrug

 #111
20170095433
2017-04-06

Ibuprofen for Topical Administration

 #112
20170081654
2017-03-23

Method for monomerizing matrix metalloproteinase 7 (MMP-7) aggregate

 #113
20170049778
2017-02-23

Treatment of erectile dysfunction and other indications

 #114
20170049758
2017-02-23

Liquid formulations containing picosulfate and magnesium citrate

 #115
20170049721
2017-02-23

Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof

 #116
20170035770
2017-02-09

Treatment of erectile dysfunction and other indications

 #117
20170027942
2017-02-02

Treatment of erectile dysfunction and other indications

 #118
20160376229
2016-12-29

Ionizable compounds and compositions and uses thereof

 #119
20160375137
2016-12-29

TARGETING LIPIDS

 #120
20160367682
2016-12-22

Nanoscale platinum compounds and methods of use thereof

 #121
20160367517
2016-12-22

Method and composition for preventing and treating viral infections

 #122
20160361352
2016-12-15

Treatment of Multiple Sclerosis With Combination of Laquinimod and Glatiramer Acetate

 #123
20160331838
2016-11-17

CARRIER COMPOSITION

 #124
20160331700
2016-11-17

Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides

 #125
20160304487
2016-10-20

Cationic lipid

 #126
20160296519
2016-10-13

Prevention of HIV-infection

 #127
20160263120
2016-09-15

Treatment of erectile dysfunction and other indications

 #128
20160243242
2016-08-25

HFSH AQUEOUS FORMULATION

 #129
20160221960
2016-08-04

Hydrazinyl lipidoids and uses thereof

 #130
20160220675
2016-08-04

HYPERTONIC ANTIMICROBIAL THERAPEUTIC COMPOSITIONS

 #131
20160151436
2016-06-02

Treatment of herpes, pseudomonas, staph, and hepatitis

 #132
20160051691
2016-02-25

Carbohydrate conjugates as delivery agents for oligonucleotides

 #133
20160024046
2016-01-28

Compositions, apparatus, systems, and methods for resolving electronic excited states

 #134
20160022555
2016-01-28

Compositions, apparatus, systems, and methods for resolving electronic excited states

 #135
20160015731
2016-01-21

Topical antiviral composition containing a local anesthetic and method of making the same

 #136
20160002200
2016-01-07

Compositions, apparatus, systems, and methods for resolving electronic excited states

 #137
20160000773
2016-01-07

Liquid pharmaceutical formulations of palonosetron

 #138
20150343062
2015-12-03

Cationic lipid

 #139
20150283212
2015-10-08

ORAL CALCITONIN COMPOSITIONS AND APPLICATIONS THEREOF

 #140
20150203439
2015-07-23

Aminoalcohol lipidoids and uses thereof

 #141
20150174261
2015-06-25

Cationic lipid

 #142
20150119445
2015-04-30

Carbohydrate conjugates as delivery agents for oligonucleotides

 #143
20150119444
2015-04-30

Carbohydrate conjugates as delivery agents for oligonucleotides

 #144
20150119440
2015-04-30

Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof

 #145
20150099000
2015-04-09

Polyamine derivatives

 #146
20150057239
2015-02-26

Solid oral pharmaceutical compositions for isoxazoline compounds

 #147
20150044276
2015-02-12

Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery

 #148
20150011615
2015-01-08

Carbohydrate conjugates as delivery agents for oligonucleotides

 #149
20140314698
2014-10-23

Aldehyde dehydrogenase inhibitors as novel depigmenting agents

 #150
20140243765
2014-08-28

PERCUTANEOUSLY ABSORBABLE PREPARATION CONTAINING FENTANYL AND HOMOLOGUE THEREOF

 #151
20140179761
2014-06-26

Targeting lipids

 #152
20140161773
2014-06-12

Use of an agent that restores tissue perfusion and oxygenation

 #153
20140097114
2014-04-10

Liquid pharmaceutical formulations of palonosetron

 #154
20140072559
2014-03-13

Highly concentrated aqueous protein solution with reduced viscosity

 #155
20140050775
2014-02-20

Polyamine derivatives

 #156
20130266641
2013-10-10

Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof

 #157
20130251809
2013-09-26

Polyamine derivatives

 #158
20130196853
2013-08-01

Matrix composition for delivery of hydrophobic actives

 #159
20130108685
2013-05-02

Cationic lipid

 #160
20130079404
2013-03-28

Topical formulation

 #161
20130029916
2013-01-31

TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND GLATIRAMER ACETATE

 #162
20120329875
2012-12-27

Ibuprofen for topical administration

 #163
20120230913
2012-09-13

PROTEIN NANOPARTICLE DISPERSIONS

 #164
20120225133
2012-09-06

Use of an agent that restores tissue perfusion and oxygenation

 #165
20120202841
2012-08-09

Topical compositions comprising ascomycins

 #166
20120202780
2012-08-09

CARRIER COMPOSITION

 #167
20120189571
2012-07-26

Nanoscale platinum compounds and methods of use thereof

 #168
20120177698
2012-07-12

AGGREGATES WITH INCREASED DEFORMABILITY, COMPRISING AT LEAST THREE AMPHIPATS, FOR IMPROVED TRANSPORT THROUGH SEMI-PERMEABLE BARRIERS AND FOR THE NON-INVASIVE DRUG APPLICATION IN VIVO, ESPECIALLY THROUGH THE SKIN

 #169
20120171281
2012-07-05

Formulations of volatile anesthetics and methods of use for reducing inflammation

 #170
20120136042
2012-05-31

Carbohydrate conjugates as delivery agents for oligonucleotides

 #171
20120129942
2012-05-24

COMPOSITIONS AND METHODS FOR TREATING FUNGAL INFECTION OF THE NAIL

 #172
20120129819
2012-05-24

GEL COMPOSITIONS FOR ADMINISTRATION OF PHARMACEUTICALLY ACTIVE COMPOUNDS

 #173
20120107255
2012-05-03

Photostabilization of cholecalciferol with alkoxycrylene compounds

 #174
20120003206
2012-01-05

Liquid, aqueous pharmaceutical compositions of factor VII polypeptides

 #175
20110293703
2011-12-01

Aminoalcohol lipidoids and uses thereof

 #176
20110268676
2011-11-03

Preservatives for Cosmetic, Toiletry and Pharmaceutical Compositions

 #177
20110223261
2011-09-15

STABLE CLEANSER COMPOSITIONS CONTAINING SULFUR

 #178
20110201554
2011-08-18

HFSH AQUEOUS FORMULATION

 #179
20110192493
2011-08-11

Liquid pharmaceutical formulations of palonosetron

 #180
20110152292
2011-06-23

SALTS COMPRISING A PYRIMIDINECARBOXYLIC ACID DERIVATIVE FOR COSMETIC USE

 #181
20110144182
2011-06-16

TREATMENT OF SURGICAL ADHESIONS

 #182
20110125076
2011-05-26

Photokinetic ocular drug delivery methods and apparatus

 #183
20110117048
2011-05-19

Method and composition for use in preparation of a patient for surgery

 #184
20110092426
2011-04-21

ORAL CALCITONIN COMPOSITIONS AND APPLICATIONS THEREOF

 #185
20110077261
2011-03-31

PREVENTION OF HIV-INFECTION

 #186
20110065809
2011-03-17

Polymerization of Multifunctional Azides, and Polymers Therefrom

 #187
20110028460
2011-02-03

Topical formulation

 #188
20100331234
2010-12-30

Aminoalcohol lipidoids and uses thereof

 #189
20100298222
2010-11-25

Use of an agent that restores tissue perfusion and oxygenation

 #190
20100278881
2010-11-04

Use of calcitonin in osteoarthritis

 #191
20100260817
2010-10-14

Polyamine derivatives

 #192
20100227920
2010-09-09

Aldehyde dehydrogenase inhibitors as novel depigmenting agents

 #193
20100137443
2010-06-03

Ibuprofen for Topical Administration

 #194
20100056453
2010-03-04

Liquid, aqueous pharmaceutical compositions of factor VII polypeptides

 #195
20100055056
2010-03-04

AGENT FOR IMPROVING PERMEATION OF A DRUG INTO A NAIL AND AN EXTERNAL TREATING AGENT CONTAINING THE SAME

 #196
20100015242
2010-01-21

USE OF A COMPOSITION FOR SKIN TREATMENT UNDER X-IRRADIATION

 #197
20090264527
2009-10-22

Method for stabilizing retinoic acid, retinoic acid containing composition, and method of using a retinoic acid containing composition

 #198
20090247752
2009-10-01

GATIFLOXACIN-CONTAINING AQUEOUS LIQUID PREPARATION, ITS PRODUCTION AND METHOD FOR SUPPRESSING FORMATION OF PRECIPITATE DURING STORAGE AT LOWER TEMPERATURE AND AT THE TIME OF FREEZING AND THAWING OF THE AQUEOUS LIQUID PREPARATION

 #199
20090247608
2009-10-01

Targeting Lipids

 #200
20090239814
2009-09-24

Carbohydrate conjugates as delivery agents for oligonucleotides

 #201
20090163484
2009-06-25

PHARMACEUTICALS CONTAINING FLUOROQUINOLONES

 #202
20090155235
2009-06-18

AGGREGATES WITH INCREASED DEFORMABILITY, COMPRISING AT LEAST THREE AMPHIPATS, FOR IMPROVED TRANSPORT THROUGH SEMI-PERMEABLE BARRIERS AND FOR THE NON-INVASIVE DRUG APPLICATION IN VIVO, ESPECIALLY THROUGH THE SKIN

 #203
20090143489
2009-06-04

Preservation of cosmetics, toiletry and pharmaceutical compositions

 #204
20090130233
2009-05-21

Two part lotion

 #205
20090074888
2009-03-19

Stable cleanser compositions containing sulfur

 #206
20090069260
2009-03-12

METHOD FOR PRODUCING A NUCLEIC-ACID-CONTAINING COMPLEX PREPARATION

 #207
20090060990
2009-03-05

NSAID FORMULATIONS, BASED ON HIGHLY ADAPTABLE AGGREGATES, FOR IMPROVED TRANSPORT THROUGH BARRIERS AND TOPICAL DRUG DELIVERY

 #208
20090060989
2009-03-05

NSAID FORMULATIONS, BASED ON HIGHLY ADAPTABLE AGGREGATES, FOR IMPROVED TRANSPORT THROUGH BARRIERS AND TOPICAL DRUG DELIVERY

 #209
20090054343
2009-02-26

Methods of therapy using pharmaceutical composition for thrombin peptide derivatives

 #210
20090042989
2009-02-12

NSAID FORMULATIONS, BASED ON HIGHLY ADAPTABLE AGGREGATES, FOR IMPROVED TRANSPORT THROUGH BARRIERS AND TOPICAL DRUG DELIVERY

 #211
20090010882
2009-01-08

Amorphous sodium 4-[4-chloro-2-hydroxybenzoyl)amino]butanoate

 #212
20080319092
2008-12-25

Transdermal Drug Delivery Formulation

 #213
20080254073
2008-10-16

Transdermal Patch Comprising Paroxetine

 #214
20080206303
2008-08-28

Prolonged Release Formulations Comprising Anastrozole

 #215
20080194601
2008-08-14

Prevention Of Hiv-Infection With Tmc278

 #216
20080175811
2008-07-24

Method and Composition For Use In Preparation of a Patient For Surgery

 #217
20080153885
2008-06-26

Pharmaceutical compositions and method for treating inflammation in cattle and other animals

 #218
20080113901
2008-05-15

Use of an agent that restores tissue perfusion and oxygenation

 #219
20080107719
2008-05-08

Transdermal drug delivery system

 #220
20080107637
2008-05-08

Use of an agent that restores tissue perfusion and oxygenation

 #221
20080103207
2008-05-01

TOPICAL CERAMIDE COMPOSITIONS AND METHODS OF USE

 #222
20080093247
2008-04-24

PACKAGING MATERIALS FOR FORMULATIONS CONTAINING 2-PYRROLIDONE DERIVATIVES

 #223
20080033204
2008-02-07

Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate

 #224
20080029083
2008-02-07

Ejection liquid and ejection method

 #225
20070249694
2007-10-25

Metaxalone formulations and methods for the preparation thereof

 #226
20070244074
2007-10-18

Stable parenteral formulation of fosphenytoin sodium

 #227
20070222842
2007-09-27

Ejection liquid, ejection device, ejection cartridge, and method of making droplets from liquid

 #228
20070206081
2007-09-06

Ejection liquid and ejection method

 #229
20070161708
2007-07-12

Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino]butanoate

 #230
20070154553
2007-07-05

Cucurbituril-containing gel and method of preparing the same

 #231
20070129328
2007-06-07

Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration

 #232
20070031483
2007-02-08

Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin

 #233
20060276374
2006-12-07

Use of an agent that restores tissue perfusion and oxygenation

 #234
20060264356
2006-11-23

Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents

 #235
20060216342
2006-09-28

Micelle delivery system loaded with a pharmaceutical agent

 #236
20060205648
2006-09-14

Liquid, aqueous pharmaceutical compositions of factor VII polypeptides

 #237
20060194722
2006-08-31

Use of calcitonin in osteoarthritis

 #238
20060167073
2006-07-27

Liquid pharmaceutical formulations of palonosetron

 #239
20060167071
2006-07-27

Liquid pharmaceutical formulations of palonosetron

 #240
20060153906
2006-07-13

Pharmaceutical product for endonasal administration for treating central nervous system disease and disorders

 #241
20060094692
2006-05-04

Pharmaceutical formulations of camptothecins and process for making same

 #242
20060093683
2006-05-04

Stable cleanser compositions containing sulfur

 #243
20060093682
2006-05-04

Stable cleanser compositions containing sulfur

 #244
20060069114
2006-03-30

Liquid pharmaceutical formulations of palonosetron

 #245
20060058279
2006-03-16

Topical compositions comprising ascomycins

 #246
20060003034
2006-01-05

Stable cleanser compositions containing sulfur

 #247
20050272639
2005-12-08

Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate

 #248
20050271725
2005-12-08

Adhesive gel composition for iontophoresis preparation and process for producing the same

 #249
20050250852
2005-11-10

Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate

 #250
20050203017
2005-09-15

Pharmaceutical composition for thrombin peptide derivatives

 #251
20050079210
2005-04-14

Liposomal delivery system for topical pharmaceutical, cosmeceutical, and cosmetic ingredients

 #252
20050064037
2005-03-24

Transdermal delivery of oxybutynin in gel formulations

 #253
20050032893
2005-02-10

Biodegradable penetration enhancers with multiple hydrophilic moieties

 #254
19222659
2026-02-17

Associated forms of nonsteroidal anti-inflammatory drugs and local anesthetics

 #255
15950870
2019-06-25

Composition and method for dual targeting in treatment of neuroendocrine tumors

 #256
15805482
2019-03-05

Self-emulsifying formulation of CARP-1 functional mimetics

 #257
15459215
2019-01-08

Self-emulsifying formulation of CARP-1 functional mimetics

 #258
13275902
2014-12-02

Absorbable polyurethanes and methods of use thereof